Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer
Drug Design, Development and Therapy · 2023-03 · Volume 17 · 901-917
DOI: 10.2147/dddt.s397969 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2023-03. Verfasst von Mei Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chinese Integrative Medicine Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Drugs, Chinese Herbal. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chinese Integrative Medicine Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.
- Department of Integrated Traditional Chinese and Western Medicine, Anhui Medical University, Hefei, People's Republic of China.
Zitieren
APA
Zhao, M., Fu, L., Xu, P., Wang, T., & Li, P. (2023). Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer. Drug Design, Development and Therapy, Volume 17, 901-917. https://doi.org/10.2147/dddt.s397969
Vancouver
Zhao M, Fu L, Xu P, Wang T, Li P. Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer. Drug Design, Development and Therapy. 2023;Volume 17:901-917. doi:10.2147/dddt.s397969
BibTeX
@article{Zhao2023,
author = {Zhao, Mei and Fu, Lijuan and Xu, Panling and Wang, Ting and Li, Ping},
title = {Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer},
journal = {Drug Design, Development and Therapy},
year = {2023},
volume = {Volume 17},
pages = {901--917},
doi = {10.2147/dddt.s397969}
}
EUVIMED